T1D

Press Releases

Tidepool Announces FDA Clearance of Tidepool Loop

Tidepool, a 501(c)3 nonprofit committed to empowering the next generation of innovations in diabetes management, today announced the FDA clearance of Tidepool Loop, an automated insulin dosing app intended for the management of type 1 diabetes (T1D) in persons six years of age and greater. “We knew this day would come, but we couldn’t have achieved it without the support…